Sensex gains 291 points on IT, pharma rally as crude oil prices ease
Synopsis
Key Takeaways
Indian equity benchmarks closed higher on Monday, 22 June, with the BSE Sensex advancing 291.17 points, or 0.38%, to settle at 77,094.07, driven by broad-based buying in information technology and pharmaceutical stocks. Easing global crude oil prices added further tailwind to investor sentiment across sectors.
The Nifty50 mirrored the gains, closing 90 points, or 0.37%, higher at 24,102.90.
Key Performers
Among the top gainers on the Nifty were Cipla, Infosys, Tech Mahindra, and Dr. Reddy's Laboratories. Sustained buying in these counters helped absorb weakness in select consumer-facing sectors. The Nifty IT, Nifty Pharma, and Nifty Healthcare indices emerged as the session's strongest sectoral performers.
On the other end, the Nifty FMCG and Nifty Consumer Durables indices closed in the red, making them the worst-performing sectors of the day.
Broader Market Holds Firm
The rally was not confined to large-caps. The Nifty MidCap index advanced 0.34%, while the Nifty SmallCap index climbed 0.6%, signalling continued investor appetite beyond frontline names. This breadth suggests the session's gains were reasonably distributed rather than driven by a handful of heavyweights.
Technical Outlook
Analysts noted that the 24,200 level remains an immediate resistance zone for the Nifty. 'A sustained breakout above this level would reinforce bullish momentum and could pave the way for a further advance towards the 24,400 region, which remains the next significant upside target,' an analyst said. On the downside, the 24,000–23,900 band is seen as a critical support zone, according to the same expert.
What Drove the Rally
Market participants pointed to the continued softening of global crude oil prices as a key sentiment booster, given India's dependence on energy imports. Defensive and technology stocks, which tend to benefit from lower input costs and stable dollar revenues respectively, attracted selective institutional interest. Notably, investors remained cautious ahead of key domestic and global economic data releases, keeping overall volumes measured.
With the Nifty hovering just below the 24,200 resistance mark, the next directional move will likely hinge on whether IT and pharma buying sustains into the week and how global cues — particularly US economic data — shape up.